Volume 14, Issue 2, Pages (August 2013)

Slides:



Advertisements
Similar presentations
Volume 39, Issue 5, Pages (November 2013)
Advertisements

Volume 26, Issue 3, Pages (March 2007)
Volume 28, Issue 5, Pages (May 2008)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 14, Issue 5, Pages (November 2013)
Volume 25, Issue 6, Pages (December 2006)
Volume 21, Issue 2, Pages (February 2017)
Volume 3, Issue 5, Pages (May 2008)
Volume 9, Issue 4, Pages (April 2011)
Volume 12, Issue 4, Pages (October 2012)
Volume 7, Issue 6, Pages (June 2001)
Volume 87, Issue 7, Pages (December 1996)
Volume 6, Issue 5, Pages (November 2009)
Volume 11, Issue 6, Pages (June 2012)
Volume 22, Issue 5, Pages (May 2012)
Volume 35, Issue 3, Pages (September 2011)
Volume 39, Issue 5, Pages (November 2013)
Volume 38, Issue 4, Pages (April 2013)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death  Piyali Mukherjee,
DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA  Jason W. Upton, William J.
Volume 16, Issue 1, Pages (January 2002)
Volume 3, Issue 5, Pages (May 2008)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 27, Issue 1, Pages (July 2007)
Volume 8, Issue 6, Pages (December 2010)
Volume 24, Issue 3, Pages (March 2006)
Volume 10, Issue 3, Pages (September 2011)
Volume 18, Issue 2, Pages (August 2015)
Volume 36, Issue 4, Pages (April 2012)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 35, Issue 3, Pages (September 2011)
Volume 17, Issue 4, Pages (April 2015)
Volume 13, Issue 4, Pages (April 2013)
Volume 38, Issue 3, Pages (May 2010)
Volume 3, Issue 1, Pages (July 2014)
Volume 25, Issue 5, Pages (November 2006)
Granulin Is a Soluble Cofactor for Toll-like Receptor 9 Signaling
CD46 Is a Cellular Receptor for Human Herpesvirus 6
Volume 12, Issue 2, Pages (August 2012)
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 30, Issue 2, Pages (February 2009)
Volume 30, Issue 3, Pages (March 2009)
Volume 16, Issue 6, Pages (December 2014)
Volume 16, Issue 1, Pages (July 2014)
Volume 9, Issue 4, Pages (April 2011)
Virus-Induced Abl and Fyn Kinase Signals Permit Coxsackievirus Entry through Epithelial Tight Junctions  Carolyn B. Coyne, Jeffrey M. Bergelson  Cell 
Poxviral B1 Kinase Overcomes Barrier to Autointegration Factor, a Host Defense against Virus Replication  Matthew S. Wiebe, Paula Traktman  Cell Host.
Volume 5, Issue 5, Pages (May 2009)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Dan Yu, Rongdiao Liu, Geng Yang, Qiang Zhou  Cell Reports 
Volume 16, Issue 1, Pages (January 2006)
Volume 8, Issue 2, Pages (August 2010)
Coxsackievirus Entry across Epithelial Tight Junctions Requires Occludin and the Small GTPases Rab34 and Rab5  Carolyn B. Coyne, Le Shen, Jerrold R. Turner,
Volume 3, Issue 1, Pages (January 2013)
Volume 125, Issue 4, Pages (May 2006)
Volume 33, Issue 5, Pages (November 2010)
Volume 9, Issue 2, Pages (February 2011)
Volume 6, Issue 2, Pages (August 2009)
Volume 2, Issue 6, Pages (December 2007)
Volume 28, Issue 5, Pages (May 2008)
Volume 17, Issue 3, Pages (March 2015)
Volume 1, Issue 2, Pages (April 2007)
A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program
Volume 14, Issue 1, Pages (July 2013)
Volume 12, Issue 6, Pages (March 2002)
Volume 38, Issue 3, Pages (March 2013)
Volume 31, Issue 5, Pages (September 2008)
Volume 11, Issue 6, Pages (June 2012)
Presentation transcript:

Volume 14, Issue 2, Pages 136-147 (August 2013) Enveloped Viruses Disable Innate Immune Responses in Dendritic Cells by Direct Activation of TAM Receptors  Suchita Bhattacharyya, Anna Zagórska, Erin D. Lew, Bimmi Shrestha, Carla V. Rothlin, John Naughton, Michael S. Diamond, Greg Lemke, John A.T. Young  Cell Host & Microbe  Volume 14, Issue 2, Pages 136-147 (August 2013) DOI: 10.1016/j.chom.2013.07.005 Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 1 Gain- and Loss-of-Function Studies for Evaluating the Impact of TAM Receptors on Virus Infection (A) Existing model of TAM receptor-ligand facilitation of enveloped virus entry. PtdSer, phosphatidylserine. (B) Immunoblots showing expression of individual TAM receptors in HEK 293T cells either untransfected (293) or stably transfected with individual TAM receptors. (C) Levels of HIV-1 viral DNA produced 24 hr postinfection of the indicated HEK 293T transformants (from B) by pseudotyped viruses bearing envelope glycoproteins from VSVg, Ebola, Marburg, or MLV-A viruses. Levels shown were normalized to those obtained with untransfected HEK 293T cells for each pseudotype (defined as 100%, dashed blue line). (D) Immunoblots showing constitutive activation of all three types of TAM receptor in HEK 293T cells that ectopically express Axl. First, TAM receptors were immunoprecipitated with the indicated antibodies and subjected to SDS-PAGE before being immunobloted with receptor-specific antibodies (IB: Tyro3, Axl, or Mer) or with a phosphotyrosine-specific antibody (IB: pY). (E) BMDCs generated from WT or specific TAM receptor knockout mice were infected with HIV-1-derived virus pseudotyped with the indicated viral glycoproteins, and the levels of reverse transcribed HIV-1 DNA were measured at 24 hr postinfection. Levels shown were normalized to those seen with WT BMDCs for each pseudotype (100%, dashed blue line). A, Axl; M, Mer; T, Tyro3; KO, single knockout; DKO, double knockout; TKO triple TAM receptor knockout. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Error bars are SEM of samples from three independent experiments. VSVg, EbGP, MARVGP, and MLV-A denote the glycoproteins of vesicular stomatitis, Ebola, Marburg, and amphotropic murine leukemia virus, respectively. See also Figure S1. Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 2 TAM Activity Stimulates Postentry Events during Virus Infection (A) BMDCs prepared from wild-type (WT, blue) or Axl−/−Mer−/− (AM DKO, red) mice were infected with VSVg-pseudotyped HIV-1-derived viruses carrying a Vpr-BLAM fusion protein (see the Experimental Procedures) and maintained at either 4°C or 37°C, as indicated, for 4 hr. Then, cells were loaded with the fluorescent β-lactamase (BLAM) substrate CCF2, and BLAM activity was assayed. Error bars are SD of six samples. Results are representative of three independent experiments. (B) Axl-transfected (293 Axl) and kinase-dead Axl-transfected (293 AxlKD) HEK 293T cells were treated with (+) or without (−) 10 nM recombinant mouse Gas6, and lysates from these cells were immunoprecipitated with anti-HA. (The cDNA expression constructs for both Axl proteins were HA-tagged.) Protein equivalents of the IPs were immunoblotted with anti-pY (top blot) or anti-HA (bottom blot). (C) Wild-type (293 WT, panels 1–3), Axl-transfected (293 Axl, panel 4), and kinase-dead Axl-transfected (293 AxlKD, panel 5) stable HEK 293T cell lines were infected with WNV at moi = 10, and the presence of internalized WNV was scored by confocal immunofluorescence microscopy for WNV E protein (E16, red, panels 1 and 3–5) at 4 hr postinfection. Panel 2 is a control staining with a monoclonal antibody (CHKV-152) against chikungunya virus. Nuclei of HEK 293T cells are visualized with DAPI (blue). One representative of three independent experiments is shown. (D) Axl-transfected (Axl, blue) and kinase-dead Axl-transfected (293 AxlKD, red) stable HEK 293T cell lines were infected with WNV at moi = 0.01 and scored for virus replication as plaque-forming units (PFU; see the Experimental Procedures) at 4 and 24 hr postinfection. Error bars are SD of three samples. Results are representative of three independent experiments. Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 3 Enveloped Virus Potentiates Ligand-Dependent TAM Receptor Activation (A) Left, WT BMDCs were incubated with increasing concentrations (0.5–2 nM) of purified human Protein S (Pros1), in either Gla-depleted cell culture medium alone (medium) or along with enveloped VSVg-pseudotyped HIV-1-derived virus that was produced in Gla-depleted medium (VSVg). Cell lysates were prepared for immunoblot 5 min after virus and/or Pros1 challenge. Mer was specifically immunoprecipitated from these samples, subjected to SDS-PAGE, and immunoblotted with a phosphotyrosine-specific antibody (IB: pY). Immunoblot analysis was used to confirm equal amounts of Mer in each sample (IB: Mer), and the amount of protein in each lysate was assessed by immunoblot for Gapdh (IB: Gapdh). Right, virus potentiation of Mer autophosphorylation in the presence of 1 nM Pros1 for 5 min is seen for the enveloped VSVg-pseudotyped virus, but not with WT MAV-1, a nonenveloped virus. (B) Left, the same experiments as in (A, left) except that WT BMDCs were incubated with 0.25–1 nM of recombinant mouse Gas6 (Gas6), and the tyrosine autophosphorylation of Axl was monitored (IB: pY). Right, Virus potentiation of Axl autophosphorylation in the presence of 1 nM Gas6 was seen only with the enveloped VSVg-pseudotyped virus and not with the nonenveloped MAV-1. (C) Microtiter wells, precoated with purified BSA, Gas6, or Pros1 (10 μg/ml ON for each protein) and incubated with equivalent amounts of VSVg-HIV (50 ng/ml p24 concentration) at 37°C for 2 hr with or without 5 mM EDTA, and the amount of bound virus was measured by ELISA for p24 protein (see Experimental Procedures). Error bars are SD of three samples. Results are representative of three independent experiments. See also Figure S2. Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 4 Enveloped Virus Infection Abrogates the Cellular Antiviral Response in a TAM-Dependent Manner (A–C) WT BMDCs (blue bars) or TAM TKO BMDCs (red bars) were challenged with the pseudotyped viruses of Figure 1B. Expression levels of IFNα4 (A), IFNβ (B), and SOCS1 (C) mRNAs were measured by qRT-PCR at the indicated time points after virus addition. The levels of the indicated mRNAs were normalized to control β-actin mRNA. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. Results comparable to those for IFNα4 and IFNβ mRNAs were seen for measurements of TNFα, IRF-5, and IRF-7 mRNAs (see Figure S3). Error bars are SEM of samples from three independent experiments. See also Figure S3. Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 5 The Primary Effect of TAM Receptor-Ligand Interactions on Virus Infection in BMDCs Is to Inhibit the Cellular Antiviral Response (A) WT BMDCs and TAM TKO BMDCs were incubated with VSVg-pseudotyped virus in either the absence (−) or presence (+) of 100 μg each of neutralizing anti-mouse IFNα and IFNβ antibodies, and the levels of HIV-1 DNA were measured at 24 hr postinfection. Results were normalized to the level of viral DNA seen with WT BMDCs incubated with no antibody (100%, dashed blue line). ∗∗∗p < 0.001. Error bars are SEM of samples from three independent experiments. (B) WT BMDCs were preincubated for 30 min with or without BMS-777607 and stimulated with Gas6 for 10 min. Receptor activation was monitored with the immunoprecipitation and immunoblotting protocol shown in Figure 3; this protocol employed a phosphotyrosine-specific antibody (pY). Immunoblot was used to confirm equal amounts of Mer and Axl in each sample. (C) WT BMDCs and TAM TKO BMDCs were incubated with EbGP-pseudotyped virus in the absence (−) or presence (+) of 300 nM BMS-777607, and the levels of HIV-1 viral DNA were measured at 24 hr postinfection. Results were normalized to those seen with WT BMDCs (100%, dashed blue line). ∗∗p < 0.01. Error bars are SEM of samples from three independent experiments. (D) WT BMDCs (blue bars), AM DKO BMDCs (red bars), and IFNAR KO BMDCs (green bars) were incubated with WNV in the absence (−) or presence (+) of 1 μM BMS-777607, and the levels of infectious virus (PFU per ml) were measured at 24 hr postinfection. ∗∗∗p < 0.001. Error bars are SEM of three independent samples. Results are representative of three independent experiments. BMS-777607 effects are not due to cytotoxicity (see Figure S4). Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions

Figure 6 Virus-Ligand Activation TAM of TAM Receptors Inhibits the Antiviral Immune Response A model showing that the major effect of TAM receptor-ligand interactions on enveloped virus infection of dendritic cells is at the level of inhibiting the cellular innate immune response, including TAM inhibition of type I IFN signaling. Cell Host & Microbe 2013 14, 136-147DOI: (10.1016/j.chom.2013.07.005) Copyright © 2013 Elsevier Inc. Terms and Conditions